Related Experiment Video
Updated: Aug 6, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Molecular targets and cancer therapeutics: discovery, development & clinical validation--AACR-NCI-EORTC international
1CRC Centre for Cancer Therapeutics at The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK. rosanne@icr.ac.uk
Abstract:
This meeting covered a wide area of cancer research including the latest developments in drug discovery, new targets and translational research into the clinic. A flavor of this meeting is reported here.
Insights
This summary highlights recent advancements in cancer research, focusing on novel drug discovery, therapeutic targets, and clinical translation. Explore the latest innovations shaping the future of cancer treatment.
Area of Science:
- Oncology
- Translational Medicine
- Pharmacology
Background:
- Cancer research is rapidly evolving.
- There is a continuous need for novel therapeutic strategies.
- Bridging basic science and clinical application is crucial.
Purpose of the Study:
- To provide an overview of a recent cancer research meeting.
- To highlight key developments in drug discovery and target identification.
- To showcase progress in translational research.
Main Methods:
- Meeting summary and report.
- Review of presented cancer research topics.
- Synthesis of information on drug discovery and clinical translation.
Main Results:
- Latest advancements in cancer drug discovery were discussed.
- New therapeutic targets were identified.
- Progress in translating research findings to clinical practice was presented.
Conclusions:
- The cancer research landscape is dynamic and innovative.
- Continued focus on drug discovery and translational research is vital.
- Future cancer therapies will benefit from these advancements.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers